Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.42 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.42 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | LCK | P06239 | 1/20 | 0.41 |
| ▸ | PPARD | Q03181 | 1/20 | 0.41 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.41 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.39 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.39 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27706517 | 0.82 | GPR84 (0.53) | GPR84FFAR1ZDHHC7MAPTLCK | |
| SCHEMBL28245824 | 0.82 | GPR84 (0.53) | GPR84FFAR1ZDHHC7MAPTLCK | |
| SCHEMBL28766385 | 0.82 | GPR84 (0.53) | GPR84FFAR1ZDHHC7MAPTLCK | |
| SCHEMBL30775240 | 0.82 | GPR84 (0.53) | GPR84FFAR1ZDHHC7MAPTLCK | |
| SCHEMBL11531633 | 0.82 | GPR84 (0.53) | GPR84FFAR1ZDHHC7MAPTLCK | |
| SCHEMBL8455146 | 0.82 | GPR84 (0.53) | GPR84FFAR1ZDHHC7MAPTLCK | |
| SCHEMBL7674274 | 0.82 | GPR84 (0.53) | GPR84FFAR1ZDHHC7MAPTLCK | |
| SCHEMBL9954371 | 0.82 | ZDHHC7 (0.47) | GPR84FFAR1ZDHHC7MAPTLCK | |
| SCHEMBL3823038 | 0.82 | GPR84 (0.53) | GPR84FFAR1ZDHHC7MAPTLCK | |
| SCHEMBL28176068 | 0.82 | GPR84 (0.53) | GPR84FFAR1ZDHHC7MAPTLCK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2034949-B2 | METHOD FOR INCREASING THE SUN PROTECTION FACTOR OF A COSMETIC AND/OR DERMATOLOGICAL PREPARATION | BASF SE (DE) | 2023-06-28 | — | — | EP | disclosed |
| EP-3630296-A1 | USE OF SPECIFIC POLYMERS TO BRING ABOUT AN ANTI-POLLUTION EFFECT | BASF SE (DE) | 2020-04-08 | — | — | EP | disclosed |
| WO-2018215136-A1 | USE OF SPECIFIC POLYMERS TO BRING ABOUT AN ANTI-POLLUTION EFFECT | BASF SE (DE) | 2018-11-29 | — | — | WO | disclosed |
| US-7537775-B2 | Low pH skin care compositions containing dehydroacetic acid | THE PROCTER & GAMBLE COMPANY (US) | 2009-05-26 | — | — | US | disclosed |
| US-20060165741-A1 | Low pH skin care compositions containing dehydroacetic acid | THE PROCTER & GAMBLE COMPANY | 2006-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060165741-A1 | Low pH skin care compositions containing dehydroacetic acid | CUTA, DHCR7, CD44 | GPR84 1142/4885FFAR1 928/4885ZDHHC7 243/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.